Regulation and role of the a typical PKC isoforms in cell survival during tumor transformation

Advances in Enzyme Regulation

Volumn 41, Issue 1, 2001, Pages 99-120

  Moscat, Jorge ^a   Sanz, Laura ^a   Sanchez, Pilar ^a   Diaz Meco, María T ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CASPASE 9; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; MESSENGER RNA; MITOGENIC AGENT; PROTEIN KINASE C; PROTEIN P62; RAS PROTEIN; TUMOR NECROSIS FACTOR ALPHA; ZINC FINGER PROTEIN; APOPTOSIS REGULATORY PROTEIN; CALCIUM; CARRIER PROTEIN; CHUK PROTEIN, HUMAN; I KAPPA B KINASE; IKBKB PROTEIN, HUMAN; IKBKE PROTEIN, HUMAN; ISOPROTEIN; P62 PROTEIN, HUMAN; PROSTATE APOPTOSIS RESPONSE 4 PROTEIN; PROSTATE APOPTOSIS RESPONSE-4 PROTEIN; PROTEIN; PROTEIN KINASE C ZETA; PROTEIN SERINE THREONINE KINASE; RNA BINDING PROTEIN; SIGNAL PEPTIDE; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; DOWN REGULATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; BIOLOGICAL MODEL; CELL DIVISION; CELL LINE; CELL TRANSFORMATION; CHEMISTRY; DOMINANT GENE; ENZYME ACTIVATION; GENETICS; METABOLISM; PHYSIOLOGY; PROTEIN BINDING; SIGNAL TRANSDUCTION;

ANIMALIA; MUS MUSCULUS;

APOPTOSIS REGULATORY PROTEINS; CALCIUM; CARRIER PROTEINS; CELL DIVISION; CELL LINE; CELL SURVIVAL; CELL TRANSFORMATION, NEOPLASTIC; DOWN-REGULATION; ENZYME ACTIVATION; GENES, DOMINANT; HUMANS; I-KAPPA B KINASE; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MAP KINASE SIGNALING SYSTEM; MODELS, BIOLOGICAL; OLIGONUCLEOTIDES, ANTISENSE; PROTEIN BINDING; PROTEIN ISOFORMS; PROTEIN KINASE C; PROTEIN-SERINE-THREONINE KINASES; PROTEINS; RNA-BINDING PROTEINS; SIGNAL TRANSDUCTION; TNF RECEPTOR-ASSOCIATED FACTOR 6; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034743875     PISSN: 00652571     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-2571(00)00009-1     Document Type: Article

References (97)

1. A new member of the third class in the protein kinase C family, PKC lambda, expressed dominantly in an undifferentiated mouse embryonal carcinoma cell line and also in many tissues and cells
2. Protein kinase C zeta isoform is critical for kappa B-dependent promoter activation by sphingomyelinase
3. Purification and characterization of the zeta isoform of protein kinase C from bovine kidney
4. Activation of the zeta isozyme of protein kinase C by phosphatidylinositol 3,4,5-trisphosphate
5. Regulation of ceramide production and apoptosis
6. Evidence for a role of protein kinase C zeta subspecies in maturation of Xenopus laevis oocytes
7. Inhibition of protein kinase C zeta subspecies blocks the activation of an NF-kappa B-like activity in Xenopus laevis oocytes
8. Protein kinase C zeta isoform is critical for mitogenic signal transduction
9. Evidence for a role of MEK and MAPK during signal transduction by protein kinase C zeta
10. A dominant negative protein kinase C zeta subspecies blocks NF-kappa B activation
11. The product of par-4, a gene induced during apoptosis, interacts selectively with the atypical isoforms of protein kinase C
12. Stress-activated protein kinases in cardiovascular disease
13. Protein phosphatase 2A is a critical regulator of protein kinase C zeta signaling targeted by SV40 small t to promote cell growth and NF-kappaB activation
14. Interleukin-1beta activates protein kinase C zeta in renal mesangial cells. Potential role in prostaglandin E2 up-regulation
15. Modulation of zeta-protein kinase C by cyclic AMP in PC12 cells occurs through phosphorylation by protein kinase A
16. EGF or PDGF receptors activate atypical PKClambda through phosphatidylinositol 3-kinase
17. Evidence for the in vitro and in vivo interaction of Ras with protein kinase C zeta
18. Protein kinase C-zeta mediates angiotensin II activation of ERK1/2 in vascular smooth muscle cells
19. Evidence for a bifurcation of the mitogenic signaling pathway activated by Ras and phosphatidylcholine-hydrolyzing phospholipase C
20. Reversion of Ras- and phosphatidylcholine-hydrolyzing phospholipase C- mediated transformation of NIH 3T3 cells by a dominant interfering mutant of protein kinase C lambda is accompanied by the loss of constitutive nuclear mitogen-activated protein kinase/extracellular signal-regulated kinase activity
21. Localization of atypical protein kinase C isoforms into lysosome-targeted endosomes through interaction with p62
22. Commonality of the gene programs induced by effectors of apoptosis in androgen-dependent and -independent prostate cells
23. Diacylglycerol generated by exogenous phospholipase C activates the mitogen-activated protein kinase pathway independent of Ras- and phorbol ester-sensitive protein kinase C: Dependence on protein kinase C-zeta
24. Activation of the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway by conventional, novel, and atypical protein kinase C isotypes
25. Role of diacylglycerol-regulated protein kinase C isotypes in growth factor activation of the Raf-1 protein kinase
26. Lambda-interacting protein, a novel protein that specifically interacts with the zinc finger domain of the atypical protein kinase C isotype lambda/iota and stimulates its kinase activity in vitro and in vivo
27. Protein kinase C-zeta mediates NF-kappa B activation in human immunodeficiency virus-infected monocytes
28. The interaction of p62 with RIP links the atypical PKCs to NF-kappaB activation
29. Activation of IkappaB kinase beta by protein kinase C isoforms
30. The atypical PKC-interacting protein p62 channels NF-kappaB activation by the IL-1-TRAF6 pathway
31. The NF-kappa B and I kappa B proteins: New discoveries and insights
32. Rel/NF-kappa B/I kappa B family: Intimate tales of association and dissociation
33. Acytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB
34. IKK-1 and IKK-2: Cytokine-activated IkappaB kinases essential for NF- kappaB activation
35. Identification and characterization of an IkappaB kinase
36. IkappaB kinase-beta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK
37. The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation
38. PKC zeta is a molecular switch in signal transduction of TNF-alpha, bifunctionally regulated by ceramide and arachidonic acid
39. Zeta PKC induces phosphorylation and inactivation of I kappa B-alpha in vitro
40. NF-kappaB-inducing kinase activates IKK-alpha by phosphorylation of Ser-176
41. Activation of the heterodimeric IkappaB kinase alpha (IKKalpha)-IKKbeta complex is directional: IKKalpha regulates IKKbeta under both basal and stimulated conditions
42. Protein kinase C-theta participates in NF-kappaB activation induced by CD3-CD28 costimulation through selective activation of IkappaB kinase beta
43. Differential regulation of IkappaB kinase alpha and beta by two upstream kinases, NF-kappaB-inducing kinase and mitogen-activated protein kinase/ERK kinase kinase-1
44. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death
45. Activation of the IkappaB alpha kinase complex by MEKK1, a kinase of the JNK pathway
46. MEK kinase 1 is critically required for c-Jun N-terminal kinase activation by proinflammatory stimuli and growth factor-induced cell migration
47. Determination of the specific substrate sequence motifs of protein kinase C isozymes
48. Severe liver degeneration in mice lacking the IkappaB kinase 2 gene
49. The IKKbeta subunit of IkappaB kinase (IKK) is essential for nuclear factor kappaB activation and prevention of apoptosis
50. Abnormal morphogenesis but intact IKK activation in mice lacking the IKKalpha subunit of IkappaB kinase
51. MAP3K-related kinase involved in NF-kappaB induction by TNF CD95, and IL-1
52. Early lethality, functional NF-kappaB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice
53. The death domain kinase RIP mediates the TNF-induced NF-kappaB signal
54. TNF-dependent recruitment of the protein kinase RIP to the TNF receptor - 1 signaling complex
55. Interaction of protein kinase C zeta with ZIP, a novel protein kinase C-binding protein
56. Phosphatidylinositol 3-kinase-dependent activation of protein kinase C-zeta in bacterial lipopolysaccharide-treated human monocytes
57. IRAK: A kinase associated with the interleukin-1 receptor
58. TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling
59. Tumor necrosis factor (TNF)-mediated kinase cascades: Bifurcation of nuclear factor-kappaB and c-jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor-associated factor 2
60. Differential stimulation of PKC phosphorylation of potassium channels by ZIP1 and ZIP2
61. Association of the p75 neurotrophin receptor with TRAF6
62. The kinase TAK1 can activate the NIK-I kappaB as well as the MAP kinase cascade in the IL-1 signalling pathway
63. Functional interactions of transforming growth factor beta-activated kinase 1 with IkappaB kinases to stimulate NF-kappaB activation
64. ECSIT is an evolutionarily conserved intermediate in the Toll/IL-1 signal transduction pathway
65. Signaling by proinflammatory cytokines: Oligomerization of TRAF2 and TRAF6 is sufficient for JNK and IKK activation and target gene induction via an amino-terminal effector domain
66. MEKK1 activates both IkappaB kinase alpha and IkappaB kinase beta
67. Tumor necrosis factor receptor-associated factors (TRAFs) - A family of adapter proteins that regulates life and death
68. Structural basis for self-association and receptor recognition of human TRAF2
69. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways
70. Impaired cytokine signaling in mice lacking the IL-1 receptor- associated kinase
71. Expression and function of the leucine zipper protein Par-4 in apoptosis
72. Par-4 is a mediator of neuronal degeneration associated with the pathogenesis of Alzheimer disease
73. Fibroblast growth factor-2 suppression of tumor necrosis factor alpha- mediated apoptosis requires Ras and the activation of mitogen-activated protein kinase
74. Insulin-like growth factor I inhibits apoptosis using the phosphatidylinositol 3′-kinase and mitogen-activated protein kinase pathways
75. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis
76. TNF- and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-kappaB
77. IEX-1L, an apoptosis inhibitor involved in NF-kappaB-mediated cell survival
78. Death receptors: Signaling and modulation
79. The activation of p38 and apoptosis by the inhibition of Erk is antagonized by the phosphoinositide 3-kinase/Akt pathway
80. Activation of nuclear factor-kappab-dependent transcription by tumor necrosis factor-alpha is mediated through phosphorylation of RelA/p65 on Serine 529
81. Oncogenic Ha-Ras-induced signaling activates NF-kappaB transcriptional activity, which is required for cellular transformation
82. Requirement of NF-kappaB activation to suppress p53-independent apoptosis induced by oncogenic Ras
83. Ras signalling and apoptosis
84. Cell cycle: Routine role for Ras
85. Akt phosphorylation of BAD couples survival signals to the cell- intrinsic death machinery
86. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt
87. Regulation of cell death protease caspase-9 by phosphorylation
88. The Drosophila gene hid is a direct molecular target of Ras-dependent survival signaling
89. Ras promotes cell survival in Drosophila by down-regulating hid expression
90. The downregulation of the pro-apoptotic protein Par-4 is critical for Ras-induced survival and tumor progression
91. Inactivation of the inhibitory kappaB protein kinase/nuclear factor kappaB pathway by Par-4 expression potentiates tumor necrosis factor alpha-induced apoptosis
92. Anovel anti-apoptosis gene, survivin, expressed in cancer and lymphoma
93. Control of apoptosis and mitotic spindle checkpoint by survivin
94. IAP family proteins-suppressors of apoptosis
95. Decreased expression of the pro-apoptotic protein Par-4 in renal cell carcinoma
96. Mutually exclusive expression patterns of Bcl-2 and Par-4 in human prostate tumors consistent with down-regulation of Bcl-2 by Par-4
97. Oncogenic ras inhibits fas ligand-mediated apoptosis by down-regulating the expression of Fas